The staging model in schizophrenia, and its clinical implications

Psychiatria Danubina

Volumn 22, Issue 2, 2010, Pages 211-220

  Agius, Mark ^a,b   Goh, Cindy ^c   Ulhaq, Sophia ^a   McGorry, Patrick ^d  

^a South Essex Partnership University Foundation Trust ^*  (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Early intervention in psychosis; Neuroimaging; Psychiatry; Schizophrenia; Staging

Indexed keywords

AUSTRALIA; CLINICAL FEATURE; CLINICAL STUDY; COGNITION; COGNITIVE THERAPY; CONFERENCE PAPER; DISEASE CLASSIFICATION; EUROPE; FAMILY THERAPY; HUMAN; MEDICAL LITERATURE; NERVE CELL DIFFERENTIATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PSYCHOEDUCATION; RELAPSE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; AUSTRALIA; BRAIN; CHRONIC DISEASE; COGNITION DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CROSS-CULTURAL COMPARISON; EUROPE; FAMILY THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, PSYCHOLOGICAL; PATIENT EDUCATION AS TOPIC; PROGNOSIS; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 77954354233     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Agius M, Bulnic Vidnjevic I, Jeric A, Furlan M, Zajdela B & Svab V: The development of community treatment in Slovenia-first outcomes. Psychiatria Danubina. 2009; 21 suppl 78-80.
2. Agius, M, Oakham, H, Biocina, SM & Murphy S: The use of cardsort exercises in the prevention of relapse in serious mental illness. Psychiatria Danubina. 2006; vol 18: 61-73
3. Agius M, Shah S, Ramkisson R, Murphy S & Zaman R: Three year outcomes of an Early Intervention For Psychosis Service as compared with treatment as usual for first psychotic episodes in a standard Community Mental Health Team-Final Results. Psychiatria Danubina. 2007; 19:130-138. (Pubitemid 47521140)
4. AJCC Cancer Staging Manual, 7th edition.
5. Amminger P, Schäfer M, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD & Berger GE: Long-chain ?-3 fatty acids for indicated prevention of psychotic disorders. A randomized, placebo-controlled trial arch. Archives of General Psychiatry. 2010; 67:146-154.
6. Archer T, Beninger RJ, Palomo T & Kostrzewa RM: Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotoxicity Research. 2010
7. Archer T, Kostrzewa RM, Palomo T & Beninger RJ: Clinical staging in the pathophysiology of psychotic and affective disorders: Facilitation of prognosis and treatment. Neurotoxicity Research. 2010.
8. Bechdolf A, et al. Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Intervention in Psychiatry 2007; 1: 71-78
9. Berger G, Dell'Olio M, Amminger P, Cornblatt B, Phillips L, Yung A, Yan Y, Berk M & McGorry P: Neuroprotection in emerging psychotic disorders. Early Intervention in Psychiatry. 2007; 1: 114-127
10. Birchwood M, Todd P & Jackson C: Early Intervention in Psychosis; The Critical Period Hypothesis. British Journal of Psychiatry 1998;172:53-59. (Pubitemid 28258899)
11. Blinc-Pesek M, Agius M, Kocmur M, Avgustin B & Perovsek-Solnic N: A study of the symptoms of early psychosis. Psychiatria Danubina. 2007. Supp 19;15.
12. Burns T Creed F, Fahy T, Thompson S, Tyrer P & White I: Intensive versus standard case management for severe psychotic illness; a randomised trial. Lancet. 1999; 353;2185-9. (Pubitemid 29295250)
13. Cannon M, Tarrant J, Huttunen M & Jones P: Childhood development and later schizophrenia; evidence from genetic high-risk and birth cohort studies.in The Epidemiology of Schizophrenia Murray RM, Jones PB, Susser E, vanOs J, Cannon M eds Cambridge University Press. 2003; 124-147.
14. Craig TKJ. Garety P, Power P , Rahaman N, Colbert S, Fornells-Ambrojo M et al. The Lambert early onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004; 329:1067-9. (Pubitemid 39490685)
15. Cullberg J, Levander S, Holmqvist R, Mattsson M, Wieselgren IM: One year outcome in first episode psychosis patients in the Swedish Parachute Project. Acta Psychiatrica Scandinavica. 2002;106:276-285.
16. Drury V et al. Cognitive therapy and recovery from acute psychosis ; a controlled trial I The impact on psychotic symptoms British Journal of Psychiatry. 1996; 169;593-601.
17. Drury V, Birchwood M et al. Cognitive therapy and recovery from acute psychosis ; a controlled trial II Impact on Recovery Time. British Journal of Psychiatry. 1996; 169; 602-607. (Pubitemid 26373162)
18. Falloon I et al. Family management in the prevention of morbidity of schizophrenia; clinical outcome of a two year longitudinal study. Archives of General Psychiatry. 1985; 42; 887-96. (Pubitemid 16248514)
19. Fava GA & Kellner R Staging: a neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica. 1993; Apr;87:225-30.
20. Fornito A, Yücel M, Wood SJ, Adamson C, Velakoulis D, Saling MM, McGorry PD & Pantelis C: Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Human Brain Mapping. 2008 Apr;29:478-89. (Pubitemid 351522140)
21. Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S, Velakoulis D, McGorry PD, Pantelis C & Yücel M: Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biological Psychiatry. 2008; Nov 1:64:758-65.
22. Freeman D, Garety P, Fowler D et al. The London -East Anglia randomised controlled trial of Cognitive therapy for Psychosis IV Self Esteem and Persecutory Delusions. British Journal of Clinical Psychology. 1998; 37;415-30. (Pubitemid 28529015)
23. Garety P, Fowler D, Kuipers E et al.: London -East Anglia randomised controlled trial of Cognitive therapy for Psychosis I I Predictors of outcome. British Journal of Psychiatry. 1997;171;420-6. (Pubitemid 27475838)
24. Garety PA, Craig TK, Dunn M, Fornells-Ambrojo M, Colbert S, Rahaman N et al.: Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. British Journal of Psychiatry 2006; 188:37-45. (Pubitemid 43021925)
25. Gruber E, Ivezic-Strkalj S & Agius M,Martic-Biocina S. 'Since I have my cas-manager, I am back to life' Case Management in Croatia. Psychiatria Danubina. 2008; 20:63-70.
26. Hafner H: Prodrome, onset, and Early Course of Schizophrenia in The Epidemiology of Schizophrenia Murray RM, Jones PB, Susser E, vanOs J, Cannon M eds Cambridge University Press 2003; p124-147.
27. Hafner H et al. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. European Archives of Psychiatry and Clinical Neurosciences. 1992; 242;109-118.
28. IRIS Guidelines North Birmingham Mental Health Trust. 1999; p19.
29. Ivezić SS, Mužinić L & Filipac V: Case management - a pillar of community psychiatry. Psychiatria Danubina. 2010 Mar;22:28-33.
30. Joa I, Johannessen JO, Auestad B, Friis S, McGlashan T, Melle I, Opjordsmoen S, Simonsen E, Vaglum P & Larsen TK: The key to reducing duration of untreated first psychosis: information campaigns. Schizophrenia Bulletin. 2008; May;3:466-72
31. Jones P, Rogers B, Murray R & Marmot M: Childhood development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994; 344; 1398-1402.
32. Johnstone EC, Frith CD, Crowe TJ, Owen D, Done D, Baldwin E & Charlette A: The Northwick Park Functional Psychosis Study: Diagnosis and Outcome. Psychological Medicine. 1992; 22:331-346.
33. Kuipers E Fowler D Garety P et al.: London -East Anglia randomised controlled trial of Cognitive therapy for Psychosis I Effects of the treatment phase. British Journal of Psychiatry. 1997; 171;319-27.
34. Kuipers E Fowler D Garety P et al. London -East Anglia randomised controlled trial of Cognitive therapy for Psychosis III Follow up and economic evaluation at 18 months . British Journal of Psychiatry. 1998;173;61-8.
35. Larsen TK, Melle I, Friis S, Joa I, Johannessen JO, Opjordsmoen S, Simonsen E, Vaglum P & McGlashan TH: One-year effect of changing duration of untreated psychosis in a single catchment area. British Journal of Psychiatry Suppl. 2007 Dec;51:128-32. (Pubitemid 350273202)
36. Leff J et al. A controlled trial of social intervention in families of schizophrenic patients . British Journal of Psychiatry. 1982;141,121-134. (Pubitemid 12092781)
37. Marjeta Blinc Pesek, Mark Agius, Bojana Avgustin, Nada Perovsek Solinc. Symptoms of early psychosis-a pilot study. Acta Psychiatrica Scandinavica. 2006; Supp vol 114; 83.
38. Marshall M , Lewis S, Lockwood A, Drake R, Jones P & Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Archives of General Psychiatry. 2005; 62 975-983. (Pubitemid 41248376)
39. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry. 2006; 163:790-799.
40. McGorry PD: Issues for DSM-V: Clinical staging: A heuristic pathway to valid nosology and safer, more effective treatment in psychiatry.McGorry PD. American Journal of Psychiatry. 2007 Jun;164:859-60.
41. McGorry PD: Staging in Neuropsychiatry: A heuristic model for understanding, prevention and treatment. Neurotox Res. 2010 Apr 3.
42. McGorry PD, Hickie IB, Yung AR, Pantelis C & Jackson HJ: Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry. 2006 Aug;40:616-22.
43. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C Jackson HJ: Clinical staging: a heuristic model for psychiatry and youth mental health. Medical Journal of Australia. 2007 Oct 1;187(7 Suppl):S40-2.
44. McGorry, PD, Yung AR. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry. 2002; Vol 59, 921-928
45. Meisenzahl EA et al. Neuroplasticity in Brain Structure of patients with schizophrenia: a 6 year Follow-up MRI study. The second dual congress on Psychiatry and the Neurosciences . Book of abstracts. Athens 2006;69.
46. Meisenzahl EM, Koutsouleris N, Gaser C, Bottlender R, Schmitt GJ, McGuire P, Decker P, Burgermeister B, Born C, Reiser M & Möller HJ. Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophrenia Research. 2008 Jul;102:150-62.
47. Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jäger M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, Burgermeister B, Reiser M, Born C & Möller HJ. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophrenia Research. 2008 Sep;104:44-60.
48. Melle I, Larsen TK, Haahr U, Friis S, Johannesen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P & McGlashan T: Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Archives of General Psychiatry. 2008 Jun;65:634-40.
49. Moller HJ: Schizophrenia: From a Neurodevelopmental to a Neuroprogressive brain Disease. The second dual congress on Psychiatry and the Neurosciences . Book of abstracts Athens. 2006;11.
50. Morrison AP , French P, Walford L et al. A randomised controlled trial of cognitive therapy for prevention of psychosis in people at ultra-high risk Schizophrenia Research. 2004; 67; 7.
51. Nordentoft M, Thorup A, Petersen L, ?hlenschlaeger J, Melau M, Christensen T, Krapup G, Jorgensen P & Jeppesen P. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophrenia Research, 2006; 83 ; 29-40.
52. Novak-Sarotar B, Blinc-Pesek M, Agius M, Pregelj P & Kocmur M. Duration of untreated psychosis and its effect on the junctional outcome of schizophrenia. Psychiatria Danubina, 2008; Vol. 20, No. 2, 179-183
53. Novak Sarotar B, Pesek MB, Agius M & Kocmur M. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - Preliminary results. Neuro Endocrinology Letters. 2008 Dec;29:990-4.
54. Pantelis et al. The Neurodevelopmental Perspective of Schizophrenia; A reassessment. The second dual congress on Psychiatry and the Neurosciences . Book of abstracts. Athens 2006; 64.
55. Pantelis C, Velakoulis D, Wood SJ, Yücel M, Yung AR, Phillips LJ, Sun DQ & McGorry PD. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. International Review of Psychiatry. 2007 Aug;19:371-81.
56. Pantelis C, Yücel M ,Wood, SJ, Velakoulis, D, Sun D, Berger G, Stuart GW, Yung A, Phillips L & McGorry P: Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin. 2005; 31:672-696. (Pubitemid 41253318)
57. Petersen L Jeppesen P, Thorup A, Abel MB, ?hlenschlaeger J, Christensen T?, et al: A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ. 2005;331:1065.
58. Presečki P. Kušan Jukić M, Martić- Biočina S, Agius M & Mimica N: Assessment of risk behaviour in psychiatric patients by a brief profile questionnaire- A pilot study. Soc.psihijat. 2010;38;28-32.
59. Rosenbaum B , Valbak K, Harder S, Knudsen P, et al: The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis. British Journal of Psychiatry. 2005;186:394-399.
60. Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ,Maier W & Klosterkötter J; LIPS study group. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. British Journal of Psychiatry. 2007; 191 (suppl. 51);88-95.
61. Ruhrmann S; Schultze-Lutter F; Salokangas R; Heinimaa M; Linszen D; Dingemans P et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Archives of General Psychiatry. 2010;67:241-251.
62. Shepherd M, Watt D, Faloon I & Smeeton N. The natural history of schizophrenia; a five year follow up in a representative sample of schizophrenics. Psychological Medicine Monograph. 1989; Supplement 15.
63. Singh SP, Cooper JE, Fisher HL, Tarrant CJ, Lloyd T, Banjo J, Corfe S & Jones P. Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS). Schizophrenia Research. 2005 Dec 1;80:117-30.
64. Spaniel F, Vohlídka P, Hrdlicka J, Kozený J, Novák T, Motlová L, Cermák J, Bednarík J, Novák D & Höschl C. ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophrenia Research. 2008 Jan;98(1-3):312-7.
65. Spaniel F, Vohlídka P, Kozený J, Novák T, Hrdlicka J, Motlová L, Cermák J & Höschl C: The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up. International Journal of Clinical Practice. 2008 Dec;62:1943-6.
66. Spencer MD, Moorhead TW, McIntosh AM, Stanfield AC, Muir WJ, Hoare P, Owens DG, Lawrie SM & Johnstone EC. Grey matter correlates of early psychotic symptoms in adolescents at enhanced risk of psychosis: a voxel-based study. Neuroimage. 2007;35:1181-91.
67. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, van Erp TG, Thompson PM, Toga AW, Cannon TD & Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophrenia Research. 2009 Mar;108:85-92.
68. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, van Erp TG, Thompson PM, Toga AW, Smith DJ, Cannon TD & Pantelis C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry. 2009 Oct;14:976-86.
69. Takahashi T, Wood SJ, Yung AR, Walterfang M, Phillips LJ, Soulsby B, Kawasaki Y, McGorry PD & Suzuki M: Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis. British Journal of Psychiatry. 2010 Mar;196:206-11.
70. Takahashi T, Wood SJ, Yung AR, Soulsby B, McGorry PD, Suzuki M, Kawasaki Y, Phillips LJ, Velakoulis D & Pantelis C: Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry. 2009 Apr;66:366-76.
71. UK700 Group Comparison of intensive and standard case management for patients with psychosis. Rationale of the trial British Journal of Psychiatry 1999; 174;74-8.
72. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P & Pantelis C: Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry. 2006 Feb;63:139-49.
73. Wood SJ, Pantelis C, Velakoulis D, Yücel M, Fornito A & McGorry PD: Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin. 2008 Mar;34:322-9.
74. Zaytseva Y: Efficacy of integrated program treatment of first episode patients versus standard care. Psychiatric Health. 2008;10;51-57.